Comparing the clinical outcomes between insulin-treated and non-insulin-treated patients with type 2 diabetes mellitus after coronary artery bypass surgery: A systematic review and meta-analysis

Medicine (United States)

Volumn 95, Issue 10, 2016, Pages

  Munnee, Krishna ^a   Bundhun, Pravesh K ^b   Quan, Hongzhi ^a   Tang, Zhangui ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ARTICLE; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; CORONARY ARTERY BYPASS SURGERY; EMBASE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; HEALTH; POSTOPERATIVE PERIOD; SURVIVAL RATE; TRENDS;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; POSTOPERATIVE PERIOD; SURVIVAL RATE;

EID: 84962488303     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003006     Document Type: Article

References (31)

1. Luthra S, Leiva-Juárez MM, Taggart DP. Systematic review of therapies for stable coronary artery disease in diabetic patients. Ann Thorac Surg. 2015;100:2383-2397.
2. Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Heart Fail Clin. 2016;12:117-133.
3. Luo Y, Yu X, Chen F, et al. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting. Coron Artery Dis. 2012;23:322-329.
4. Bundhun PK, Li N, Chen MH. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: A systematic review and metaanalysis. Cardiovasc Diabetol. 2015;14:135.
5. King SB 3rd, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331:1044-1050.
6. CABRI. Long-term follow-up of European revascularization trial. Presented at the 68th Scientific Sessions, Plenary Session XII, of the American Heart Association; November 16, 1995; Anaheim, Calif.
7. Dangas GD, Farkouh ME, Sleeper LA, et al. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol. 2014;64:1189-1197.
8. Alserius T, Hammar N, Nordqvist T, et al. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes. Am Heart J. 2006;152:599-605.
9. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067-1075.
10. Carson JL, Scholz PM, Chen AY, et al. Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol. 2002;40:418-423.
11. Kappetein AP, Head SJ, Morice MC, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43:1006-1013.
12. Lawrie GM, Morris GC Jr, Glaeser DH. Influence of diabetes mellitus on the results of coronary bypass surgery. Follow-up of 212 diabetic patients ten to 15 years after surgery. JAMA. 1986;256:2967-2971.
13. Li Z, Amsterdam EA, Young JN, et al. Contemporary outcomes of coronary artery bypass grafting among patients with insulin-treated and non-insulin-treated diabetes. Ann Thorac Surg. 2015;100: 2262-2269.
14. Luciani N, Nasso G, Gaudino M, et al. Coronary artery bypass grafting in type II diabetic patients: A comparison between insulindependent and non-insulin-dependent patients at short-and mid-term follow-up. Ann Thorac Surg. 2003;76:1149-1154.
15. Mohammadi S, Dagenais F, Mathieu P, et al. Long-term impact of diabetes and its comorbidities in patients undergoing isolated primary coronary artery bypass graft surgery. Circulation. 2007;116(11 Suppl):I220-I225.
16. Wit MA, de Mulder M, Jansen EK, et al. Diabetes mellitus and its impact on long-term outcomes after coronary artery bypass graft surgery. Acta Diabetol. 2013;50:123-128.
17. Nyström T, Holzmann MJ, Sartipy U. Long-term risk of stroke in patients with type 1 and type 2 diabetes following coronary artery bypassgrafting. J Am Heart Assoc. 2015;4:pii: e002411.
18. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Wiley; 2008:187-241.
19. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcareinterventions: explanation and elaboration. BMJ. 2009;339:b2700.
20. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabeticpatients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55:432-440.
21. Bundhun PK, Wu ZJ, Chen MH. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: A systematic review and meta-analysis of 6 randomized controlled trials. Cardiovasc Diabetol. 2016;15:2.
22. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961-972.
23. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: acollaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190-1197.
24. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012;366:1467-1476.
25. Deaton C, Thourani V. Patients with type 2 diabetes undergoing coronary artery bypass graft surgery: predictors of outcomes. Eur J Cardiovasc Nurs. 2009;8:48-56.
26. Koshizaka M, Lopes RD, Reyes EM, et al. Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graftsurgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. Am Heart J. 2015;169:175-184.
27. Unger RH, Orci L. Paracrinology of islets and the paracrinopathy of diabetes. Proc Natl Acad Sci USA. 2010;107:16009-16012.
28. Wang M-Y, Yu X, Lee L, et al. Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markers. J Diabetes Complications. 2013;27:70-74.
29. Muniyappa R, Montagnani M, Koh KK, et al. Cardiovascular actions of insulin. Endocr Rev. 2007;28:463-491.
30. Ingelsson E, Sundstrom J, Arnlov J, et al. Insulin resistance and risk of congestive heart failure. JAMA. 2005;294:334-341.
31. Zhang H, Yuan X, Osnabrugge RL, et al. Influence of diabetes mellitus on long-term clinical and economic outcomes after coronary artery bypass grafting. Ann Thorac Surg. 2014;97:2073-2079.